Navigating the Intersection of Finance and Biotech

Gain exclusive insights into 2025’s investment trends and career opportunities from industry leaders: Stephen Squinto, PhD, with 35 years of biotech experience (including roles at Regeneron and Alexion Pharmaceuticals); and Barry Schweitzer, PhD ’82, with 20+ years in biotech and venture capital. The conversation will be moderated by Evan Sotiriou ’98, Head of Product and Portfolio at J.P. Morgan Asset Management.
Discover Dartmouth’s cutting-edge biotech innovations, learn how to monetize scientific discoveries, and leverage the power of the Dartmouth network. A light breakfast is included. All members of the Dartmouth community are welcome.
Contact: Dartmouth Alumni Relations
Speakers
Stephen Squinto, PhD
Chief Investment Officer, Life Sciences and Healthcare Private Capital investment platform at J.P. Morgan
Barry Schweitzer, PhD, ’82
Associate Director, Strategic Initiatives at the Magnuson Center for Entrepreneurship at Dartmouth
Evan Sotiriou ’98
Head of Product and Portfolio at J.P. Morgan Asset Management
This event is co-hosted by Dartmouth Alumni Relations and the Dartmouth Club of Suburban New Jersey.